RedHill Biopharma reported $1.29M in Sales Revenues for its fiscal quarter ending in June of 2024.





Sales Change Date
Cara Therapeutics USD 2.57M 1.11M Mar/2025
Clal Biotechnology ILS 3.41M 2M Dec/2022
Compugen USD 6.35M 60.98M Mar/2026
Cronos Group USD 58.97M 580K Mar/2026
RedHill Biopharma USD 1.29M 722K Jun/2024